Evidence map›Paper›PMID 24968150›Full record

ArticlePLoS genetics2014

Abnormal type I collagen post-translational modification and crosslinking in a cyclophilin B KO mouse model of recessive osteogenesis imperfecta.

Wayne A Cabral, Irina Perdivara, MaryAnn Weis, Masahiko Terajima, Angela R Blissett, Weizhong Chang, Joseph E Perosky, Elena N Makareeva, Edward L Mertz, Sergey Leikin and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 126 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Failed Cellular Surveillance Enables Pathogenic Matrix Deposition in abioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Update on the Genetics of Osteogenesis Imperfecta.Calcified tissue international · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Wayne A CabralBone and Extracellular Matrix Branch, NICHD, NIH, Bethesda, Maryland, United States of America.
Irina PerdivaraLaboratory of Structural Biology, NIEHS, NIH, Research Triangle Park, North Carolina, United States of America.
MaryAnn WeisOrthopaedic Research Laboratories, University of Washington, Seattle, Washington, United States of America.
Masahiko TerajimaNorth Carolina Oral Health Institute, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States of America.
Angela R BlissettBone and Extracellular Matrix Branch, NICHD, NIH, Bethesda, Maryland, United States of America.
Weizhong ChangBone and Extracellular Matrix Branch, NICHD, NIH, Bethesda, Maryland, United States of America.
Joseph E PeroskyOrthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan, United States of America.
Elena N MakareevaSection on Physical Biochemistry, NICHD, NIH, Bethesda, Maryland, United States of America.
Edward L MertzSection on Physical Biochemistry, NICHD, NIH, Bethesda, Maryland, United States of America.
Sergey LeikinSection on Physical Biochemistry, NICHD, NIH, Bethesda, Maryland, United States of America.
Kenneth B TomerLaboratory of Structural Biology, NIEHS, NIH, Research Triangle Park, North Carolina, United States of America.
Kenneth M KozloffOrthopaedic Research Laboratories, Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, Michigan, United States of America.
David R EyreOrthopaedic Research Laboratories, University of Washington, Seattle, Washington, United States of America.
Mitsuo YamauchiNorth Carolina Oral Health Institute, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States of America.
Joan C MariniBone and Extracellular Matrix Branch, NICHD, NIH, Bethesda, Maryland, United States of America.
Eunice Kennedy Shriver National Institute of Child Health and Human Development · USNational Institutes of Health · USOrthopaedic Research Laboratories · USUniversity of North Carolina at Chapel Hill · USMichigan United · USNational Institute of Environmental Health Sciences · USUniversity of Washington · US

Funding

Collagen-related diseases ZIAHD000256 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI LEIKIN, SERGEY · 2009 to 2025
$19.7M
THE SKELETAL DYSPLASIASP01HD022657 · NICHD · CEDARS-SINAI MEDICAL CENTER · PI EYRE, DAVID R · 1987 to 2011
$17.0M
Project 3: Collagen post-translational modification and cross-linking in OIP01HD070394 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI LEE, BRENDAN · 2011 to 2020
$13.4M
Collagen Cross-linking in Skeletal Aging and DiseaseR37AR037318 · NIAMS · UNIVERSITY OF WASHINGTON · PI EYRE, DAVID R · 2010 to 2019
$3.4M
PATHOLOGY OF INBORN SKELETAL DISEASESR01AR037318 · NIAMS · UNIVERSITY OF WASHINGTON · PI EYRE, DAVID R · 1986 to 2009
$3.4M
Collagens of Cartilage and the Intervertebral DiscR01AR036794 · NIAMS · UNIVERSITY OF WASHINGTON · PI EYRE, DAVID R · 1986 to 2014
$3.3M
High-definition infrared micro-spectroscopic imaging of biomaterialsZIAHD008810 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI LEIKIN, SERGEY · 2009 to 2022
$2.5M
Sclerostin Antibody Therapy for Treatment of Osteogenesis ImperfectaR01AR062522 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOZLOFF, KENNETH M · 2012 to 2016
$1.8M
Collagen Glycosylation, Maturation and MineralizationR21AR060978 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI YAMAUCHI, MITSUO · 2012 to 2013
$352k
NIAMS NIH HHS AR37318NIAMS NIH HHS R01 AR036794NIAMS NIH HHS R01 AR037318NIAMS NIH HHS R01 AR062522NIAMS NIH HHS R21 AR060978NIAMS NIH HHS R37 AR037318NICHD NIH HHS HD22657NICHD NIH HHS P01 HD022657NICHD NIH HHS P01 HD070394
6 · The paper itself

Abstract

Cyclophilin B (CyPB), encoded by PPIB, is an ER-resident peptidyl-prolyl cis-trans isomerase (PPIase) that functions independently and as a component of the collagen prolyl 3-hydroxylation complex. CyPB is proposed to be the major PPIase catalyzing the rate-limiting step in collagen folding. Mutations in PPIB cause recessively inherited osteogenesis imperfecta type IX, a moderately severe to lethal bone dysplasia. To investigate the role of CyPB in collagen folding and post-translational modifications, we generated Ppib-/- mice that recapitulate the OI phenotype. Knock-out (KO) mice are small, with reduced femoral areal bone mineral density (aBMD), bone volume per total volume (BV/TV) and mechanical properties, as well as increased femoral brittleness. Ppib transcripts are absent in skin, fibroblasts, femora and calvarial osteoblasts, and CyPB is absent from KO osteoblasts and fibroblasts on western blots. Only residual (2-11%) collagen prolyl 3-hydroxylation is detectable in KO cells and tissues. Collagen folds more slowly in the absence of CyPB, supporting its rate-limiting role in folding. However, treatment of KO cells with cyclosporine A causes further delay in folding, indicating the potential existence of another collagen PPIase. We confirmed and extended the reported role of CyPB in supporting collagen lysyl hydroxylase (LH1) activity. Ppib-/- fibroblast and osteoblast collagen has normal total lysyl hydroxylation, while increased collagen diglycosylation is observed. Liquid chromatography/mass spectrometry (LC/MS) analysis of bone and osteoblast type I collagen revealed site-specific alterations of helical lysine hydroxylation, in particular, significantly reduced hydroxylation of helical crosslinking residue K87. Consequently, underhydroxylated forms of di- and trivalent crosslinks are strikingly increased in KO bone, leading to increased total crosslinks and decreased helical hydroxylysine- to lysine-derived crosslink ratios. The altered crosslink pattern was associated with decreased collagen deposition into matrix in culture, altered fibril structure in tissue, and reduced bone strength. These studies demonstrate novel consequences of the indirect regulatory effect of CyPB on collagen hydroxylation, impacting collagen glycosylation, crosslinking and fibrillogenesis, which contribute to maintaining bone mechanical properties.

Indexed as

AnimalsCollagenCollagen Type ICyclophilinsExtracellular MatrixGenes, RecessiveHumansMaleMembrane GlycoproteinsMiceMice, KnockoutMutationOsteogenesis ImperfectaProtein FoldingProtein Processing, Post-TranslationalCollagenCollagen Type Icyclophilin BCyclophilinsglycosylated collagenMembrane Glycoproteins

Identifiers

PMID24968150
PMCPMC4072593
OpenAlexW1965639209

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.